Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes

Thati Madhusudhan1, Hongjie Wang, Beate K Straub

  • 1Department of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University Magdeburg, Germany.

Blood
|November 26, 2011
PubMed

Insights

Activated protein C (aPC) protects kidney podocytes via a novel signaling pathway involving protease-activated receptor-3 (PAR-3) and PAR-2/PAR-1. This mechanism inhibits apoptosis and reduces kidney injury.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Activated protein C (aPC) exhibits cytoprotective effects, but its signaling mechanisms in kidney podocytes are undefined.
  • Existing knowledge indicates aPC protects glomerular endothelial cells via PAR-1 and EPCR, but podocyte-specific pathways remain elusive.

Purpose of the Study:

  • To elucidate the signaling mechanism by which aPC confers cytoprotection to podocytes.
  • To identify the specific receptors and pathways involved in aPC-mediated podocyte protection.

Main Methods:

  • Investigated aPC signaling in podocytes using biochemical assays and genetic manipulation.
  • Examined aPC-induced activation of protease-activated receptors (PARs) and their downstream effects.
  • Assessed the role of PAR-3, PAR-2, PAR-1, and caveolin-1 in aPC-mediated cytoprotection.
  • Evaluated the in vivo effects of aPC in a mouse model of podocyte injury.

Main Results:

  • Identified a novel aPC/PAR-dependent cytoprotective signaling mechanism in podocytes.
  • aPC inhibits podocyte apoptosis via proteolytic activation of PAR-3, independent of EPCR.
  • PAR-3 requires aPC-induced heterodimerization with PAR-2 (human) or PAR-1 (mouse) to signal.
  • This pathway involves caveolin-1 dephosphorylation and confers protection against LPS-induced podocyte injury and proteinuria in vivo.
  • Genetic deletion of PAR-3 abrogated the nephroprotective effects of aPC.

Conclusions:

  • Discovered a novel, cell-specific signaling mechanism for aPC in kidney podocytes involving PAR-3 and PAR-2/PAR-1 heterodimerization.
  • This pathway highlights the plasticity of aPC signaling and its dependence on specific receptor interactions.
  • Findings suggest potential for developing targeted therapies for kidney diseases based on these specific signaling complexes.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.